Reuters logo
4 个月前
BRIEF-ContraVir Pharma says TXL has completed phase 1 clinical trial in healthy volunteers, showing favorable safety, tolerability, drug distribution profile
2017年4月11日 / 上午10点12分 / 4 个月前

BRIEF-ContraVir Pharma says TXL has completed phase 1 clinical trial in healthy volunteers, showing favorable safety, tolerability, drug distribution profile

April 11 (Reuters) - ContraVir Pharmaceuticals Inc

* ContraVir Pharma- TXL has completed phase 1 clinical trial in healthy volunteers, showing favorable safety, tolerability, drug distribution profile Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below